Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Rizzuti

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
International Journal of Biological Macromolecules|July 3, 2023
The intrinsically disordered, epigenetic factor RYBP binds to the citrullinating enzyme PADI4 in cancer cellsSalomé Araujo-Abad, María Fuentes-Baile, Bruno Rizzuti, et al.
Scientific Reports|November 28, 2024
Development of an efficient NUPR1 inhibitor with anticancer activityXi Liu, Ana Jimenez-Alesanco, Zexian Li, et al.
Biochimica Et Biophysica Acta. General Subjects|April 3, 2020
Human importin α3 and its N-terminal truncated form, without the importin-β-binding domain, are oligomeric species with a low conformational stability in solutionClara Díaz-García, Felipe Hornos, A Marcela Giudici, et al.
International Immunopharmacology|February 26, 2021
Cateslytin abrogates lipopolysaccharide-induced cardiomyocyte injury by reducing inflammation and oxidative stress through toll like receptor 4 interactionCarmine Rocca, Anna De Bartolo, Fedora Grande, et al.
Journal of Translational Medicine|February 27, 2024
Targeting of mitochondrial fission through natural flavanones elicits anti-myeloma activityRoberta Torcasio, Maria Eugenia Gallo Cantafio, Claudia Veneziano, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 17, 2024
The G Protein Estrogen Receptor (GPER) is involved in the resistance to the CDK4/6 inhibitor palbociclib in breast cancerMarianna Talia, Francesca Cirillo, Domenica Scordamaglia, et al.
JCI Insight|August 12, 2020
ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agentsWenjun Lan, Patricia Santofimia-Castaño, Mirna Swayden, et al.
Scientific Reports|October 21, 2024
New insights in the mechanism of the SARS-CoV-2 M<sup>pro</sup> inhibition by benzisoselenazolones and diselenidesLuca Sancineto, Francesca Mangiavacchi, Agnieszka Dabrowska, et al.
International Journal of Molecular Sciences|July 2, 2021
Seleno-Functionalization of Quercetin Improves the Non-Covalent Inhibition of M<sup>pro</sup> and Its Antiviral Activity in Cells against SARS-CoV-2Francesca Mangiavacchi, Pawel Botwina, Elena Menichetti, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
International Journal of Biological Macromolecules|July 3, 2023
The intrinsically disordered, epigenetic factor RYBP binds to the citrullinating enzyme PADI4 in cancer cellsSalomé Araujo-Abad, María Fuentes-Baile, Bruno Rizzuti, et al.
Scientific Reports|November 28, 2024
Development of an efficient NUPR1 inhibitor with anticancer activityXi Liu, Ana Jimenez-Alesanco, Zexian Li, et al.
Biochimica Et Biophysica Acta. General Subjects|April 3, 2020
Human importin α3 and its N-terminal truncated form, without the importin-β-binding domain, are oligomeric species with a low conformational stability in solutionClara Díaz-García, Felipe Hornos, A Marcela Giudici, et al.
International Immunopharmacology|February 26, 2021
Cateslytin abrogates lipopolysaccharide-induced cardiomyocyte injury by reducing inflammation and oxidative stress through toll like receptor 4 interactionCarmine Rocca, Anna De Bartolo, Fedora Grande, et al.
Journal of Translational Medicine|February 27, 2024
Targeting of mitochondrial fission through natural flavanones elicits anti-myeloma activityRoberta Torcasio, Maria Eugenia Gallo Cantafio, Claudia Veneziano, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 17, 2024
The G Protein Estrogen Receptor (GPER) is involved in the resistance to the CDK4/6 inhibitor palbociclib in breast cancerMarianna Talia, Francesca Cirillo, Domenica Scordamaglia, et al.
JCI Insight|August 12, 2020
ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agentsWenjun Lan, Patricia Santofimia-Castaño, Mirna Swayden, et al.
Scientific Reports|October 21, 2024
New insights in the mechanism of the SARS-CoV-2 M<sup>pro</sup> inhibition by benzisoselenazolones and diselenidesLuca Sancineto, Francesca Mangiavacchi, Agnieszka Dabrowska, et al.
International Journal of Molecular Sciences|July 2, 2021
Seleno-Functionalization of Quercetin Improves the Non-Covalent Inhibition of M<sup>pro</sup> and Its Antiviral Activity in Cells against SARS-CoV-2Francesca Mangiavacchi, Pawel Botwina, Elena Menichetti, et al.
Pageof 10